Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Enteral tube feeding
Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
Purpose and principles
Select enteral access appropriately, confirm tube position without unsafe shortcuts, prescribe feed and water coherently, and prevent aspiration, metabolic, mechanical and medication-related harm.
Enteral nutrition uses a working gut when eating cannot safely or reliably meet need. Choosing a route requires an estimate of duration, gastric emptying, aspiration risk, anatomy, surgical plans, likely discharge setting and the patient's informed preferences. A gastrostomy is not simply a more durable nasogastric tube; insertion burden and longer-term goals require explicit discussion.
Nasogastric misplacement into the respiratory tract is a recognised never-event risk. Absence of coughing does not prove gastric location. Initial position checking is a controlled clinical process involving competent staff, endorsed pH testing or X-ray, accurate interpretation and documentation before anything is administered.
Once access is safe, feeding still needs active prescription and observation. Energy, protein, fibre, electrolyte and water content must fit the illness and fluid balance. Refeeding physiology, glycaemia, bowel function, tube patency, skin or stoma integrity, aspiration risk and treatment goals all change over time.
Key points
Use enteral feeding when oral intake is unsafe or inadequate but the gastrointestinal tract is sufficiently accessible and functional; the indication and intended duration determine access.
Nasogastric tubes generally suit short-term gastric feeding, post-pyloric tubes help selected gastric-intolerance or aspiration situations, and gastrostomy or jejunostomy may serve longer-term needs.
Before first use of a nasogastric tube, accept only aspirate pH within the endorsed safe range or an appropriately obtained and interpreted X-ray; never use whoosh, bubble, litmus or fluid appearance tests.
Recheck position after insertion and whenever displacement is possible, following local policy before feed, water or medicines enter the tube.
The prescription includes formula, route, rate or bolus schedule, progression, water flushes and the contribution of medications and intravenous fluids, not merely a number of feed bags.
Elevate the upper body during gastric feeding when possible, respond to vomiting or respiratory change, and address sedation, gastric delay and tube migration as aspiration determinants.
Give medicines separately with suitable water flushes and pharmacy advice; crushing modified-release, enteric-coated, cytotoxic or hazardous preparations can injure the patient or staff.
Indications, selection and cautions
Inadequate oral intake
Persistent failure to meet estimated needs despite optimised oral support may justify enteral feeding when the gut remains usable and benefit is plausible.
Unsafe swallow
Stroke, neurodegeneration, structural disease or critical illness can make swallowing unsafe even when appetite is present, requiring specialist swallowing assessment.
Gastric intolerance
Recurrent vomiting, severe reflux, high aspiration concern or delayed emptying may prompt altered rate, prokinetic review or post-pyloric access rather than immediate abandonment of enteral support.
Tube displacement
A changed external length, loose fixation, coiling in the mouth, retching, coughing or unexpected respiratory symptoms means position is no longer assured.
Feed intolerance
Distension, pain, vomiting, diarrhoea or constipation demands cause-specific assessment; the timing relative to feed, medicines and illness is more informative than the label itself.
Access complication
Leakage, granulation, pain, blockage, buried bumper features or peristomal infection should be recognised early and reviewed by staff familiar with the device.
Red flags requiring action
Acute cough, cyanosis, desaturation or respiratory distress during tube use requires immediate cessation, airway assessment and confirmation that feeding access has not entered or migrated toward the airway.
Assessment before treatment
01Nasogastric aspirate pHFirst stepFirst line
Why
Provide the first-line endorsed initial placement check when aspirate is obtainable.
Interpretation and limitations
A result in the NHS safe range of 1 to 5.5 supports gastric placement; acid suppression and continuous feeding can raise pH, while an unsafe or unobtainable result requires X-ray rather than repeated blind use.
02Placement X-ray
Why
Confirm position when pH testing cannot establish safe gastric placement.
Interpretation and limitations
A trained clinician must apply and document the full radiographic criteria, identify the entire tube course and confirm a safe distal tip before authorising use; a generic report of tube seen is insufficient.
03Nutrition and refeeding assessment
Why
Define requirements, starting intensity and risks before feed delivery.
Interpretation and limitations
Weight history, intake duration, diagnosis, fluid balance, glucose, potassium, phosphate and magnesium distinguish routine initiation from a cautious high-risk programme.
04Fluid balance and biochemistry
Why
Detect underhydration, excess free water, electrolyte losses and organ intolerance.
Interpretation and limitations
Interpret feed water, prescribed flushes, medication flushes, intravenous fluids, urine and gastrointestinal losses together rather than considering formula volume alone.
Treatment approach
01STARTInitiating enteral supportFirst stepOral intake is unsafe or insufficient and enteral feeding offers a proportionate benefit.+
1Confirm indication, expected duration, gastrointestinal function, refeeding risk, capacity and the agreed goals of treatment.
2Choose gastric or post-pyloric access with the nutrition, endoscopy, radiology or surgical team according to anatomy and aspiration factors.
3Verify position using the device-specific approved method and document authorisation before the first feed, flush or medicine.
4Begin the prescribed regimen at an appropriate rate, adding water and electrolyte plans and monitoring tolerance against explicit targets.
02CHECKNasogastric position safetyA tube has just been inserted or movement, vomiting, coughing or fixation change makes displacement possible.+
1
Regimens, contraindications and interactions
Provide calculated energy, protein, micronutrients and a defined contribution to daily fluid through usable gastrointestinal access.
Prescribed enteral feed formula
Deliver the dietitian-approved volume by the specified continuous, intermittent or bolus schedule, with staged introduction where tolerance or refeeding risk requires it.
Match formula and route to allergy, renal or hepatic disease, fibre needs and distal tube site; prevent contamination and never alter concentration casually to solve a fluid problem.
Protect against acute thiamine depletion as carbohydrate delivery and cellular metabolism increase.
Thiamine for high refeeding risk
Give immediately before and during early feeding using the current NICE-aligned local regimen and an absorbable route.
Continue careful calorie progression and potassium, phosphate, magnesium, glucose and fluid surveillance; thiamine cannot make unrestricted feeding safe.
Use only a time-limited locally approved regimen after mechanical obstruction, tube malposition and correctable medicine causes have been considered.
Metoclopramide causes neurological adverse effects and domperidone carries cardiac risk; check QT factors, interactions and current MHRA restrictions before selection.
Complications, monitoring and follow-up
At each use point defined by policy, check tube security, external length and any event that could have displaced it; repeat approved confirmation when doubt exists.
Record feed actually delivered, water flushes, other fluid input, urine, stool or stoma losses, daily clinical hydration and weight trajectory.
Check glucose, potassium, phosphate, magnesium and renal function frequently during initiation when illness or refeeding risk makes metabolic change likely.
Observe for cough, wet voice, vomiting, desaturation, chest signs and positioning factors that may indicate aspiration or unsafe gastric tolerance.
Inspect nasal skin, oral hygiene, fixation and gastrostomy or jejunostomy sites, with device-specific rotation and care only when appropriate.
Review ongoing indication, swallowing recovery, expected duration and patient preference so temporary access does not become permanent through inertia.
Special situations
Silence does not prove safety
A respiratory-tract tube can cause little coughing, particularly in neurological illness or reduced consciousness; only approved checking establishes position.
Water is part of treatment
Commercial formula does not necessarily meet total water need, while every medication flush contributes volume that matters in heart or renal failure.
Distal site changes pharmacology
Jejunal delivery bypasses gastric dissolution and may alter medicines requiring acidity, a gastric reservoir or a specific absorption segment.
Diarrhoea has many owners
Antibiotics, Clostridioides difficile, laxatives and sorbitol liquids are often more plausible than formula allergy and should be reviewed systematically.
Access follows goals
Expected benefit, duration, comfort, rehabilitation and discharge feasibility should shape tube choice; procedural durability alone is not a sufficient indication.
Common pitfalls
01
Do not use auscultated air insufflation, bubbling, blue litmus, aspirate appearance or lack of respiratory symptoms to confirm nasogastric placement.
02
Do not commence feeding from an ambiguous radiograph; competent interpretation and explicit documented authorisation are safety-critical.
03
Do not crush every tablet together into feed, because interactions, altered release, hazardous exposure and tube blockage can all result.
04
Do not attribute all loose stool to the feed and repeatedly dilute it; this can reduce nutrition while infection or medication causes persist.
05
Do not forget prescribed and medication water flushes when calculating fluid balance, particularly during restriction or high gastrointestinal loss.
06
Do not insert long-term access without discussing prognosis, capacity, goals and burdens with the patient or lawful decision-making framework.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Gastroenterology and hepatologyOriginal SBA
First-use safety
A nasogastric tube has been inserted for a drowsy stroke patient. No aspirate can be obtained, but air insufflation produces a clear sound over the epigastrium. What should happen next?
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Diarrhoea during tube feeding is not automatically formula intolerance: review antibiotics, infection, sorbitol-containing liquids, laxatives, rate, contamination and underlying bowel disease.
A newly inserted nasogastric tube without an endorsed pH result or documented acceptable X-ray must not be used for feed, water or medication.
Severe abdominal pain, rigidity, rapid distension, haemodynamic instability or free-air concern suggests perforation, ischaemia or obstruction and requires urgent surgical assessment.
Pain on gastrostomy use, new leakage, inability to rotate when appropriate, bleeding or systemic infection can indicate a serious device complication needing prompt specialist review.
Weakness, arrhythmia, oedema, delirium or respiratory deterioration after feeding starts may represent refeeding syndrome and warrants urgent electrolyte and fluid evaluation.
05Swallow and route reassessment
Why
Determine whether oral intake can resume or whether access should change for longer-term support.
Interpretation and limitations
Speech and language therapy findings, nutritional adequacy, expected duration, aspiration history and patient goals should drive transition rather than an arbitrary calendar date.
Stop all administration and inspect external length, fixation, mouth and clinical condition without relying on absence of distress.
2Attempt aspirate and test with the approved pH paper by a competent practitioner, recording the numeric result.
3If pH is outside the safe range or no aspirate is obtained, arrange X-ray and maintain nothing through the tube until competent authorisation.
4EscalationEscalate recurrent placement difficulty for guided insertion or a different route rather than repeating traumatic blind attempts indefinitely.
03TROUBLEVomiting or diarrhoea on feedNew gastrointestinal symptoms threaten delivery, hydration or aspiration safety.+
1Pause or reduce feeding when clinically necessary, assess ABCDE status, abdominal signs, tube position and aspiration features.
2Review constipation, obstruction, infection, antibiotics, laxatives, hyperosmolar or sorbitol medicines, feed rate and handling hygiene.
3Correct fluid and electrolyte losses, then modify rate, timing, fibre or formula only with nutrition-team rationale.
4AlternativeConsider post-pyloric feeding or an alternative route when a defined gastric or intestinal problem persists despite targeted measures.
04MEDSMedicines through a tubeA prescribed medicine must be delivered through enteral access.+
1Confirm tube location, diameter, distal site and whether feeding interacts with absorption, seeking pharmacy advice for each formulation.
2Prefer an appropriate licensed liquid or safe dispersible option while accounting for osmolality, sorbitol, sodium and tube compatibility.
3Stop feed only when the medicine requires it, administer drugs one at a time and flush before, between and after according to fluid and device plans.
4Document altered administration and monitor clinical effect, because jejunal delivery and crushed formulations can change exposure substantially.